Similar articles

• [High dose chemotherapy in malignant gliomas using autologous bone marrow transplantation and GM-CSF: granulocyte-macrophage colony stimulating factors].

  Yamashita J, Kawamura T, Shoin K. Yamashita J, et al. No Shinkei Geka. 1990 Apr;18(4):329-38. No Shinkei Geka. 1990. PMID: 2197571 Review. Japanese. No abstract available.
• [Stem cell-colony stimulating factors].

  Urabe A, Kobayashi Y, Takaku F. Urabe A, et al. Gan No Rinsho. 1989 May;Spec No:287-93. Gan No Rinsho. 1989. PMID: 2481048 Review. Japanese. No abstract available.
• Recombinant human granulocyte-macrophage colony-stimulating factor reduces hematologic toxicity and widens clinical applicability of high-dose cyclophosphamide treatment in breast cancer and non-Hodgkin's lymphoma.

  Gianni AM, Bregni M, Siena S, Orazi A, Stern AC, Gandola L, Bonadonna G. Gianni AM, et al. J Clin Oncol. 1990 May;8(5):768-78. doi: 10.1200/JCO.1990.8.5.768. J Clin Oncol. 1990. PMID: 2185337
• [Preventing and treating hematologic complications of anticancer chemotherapy: update on hematopoietic growth factors].

  Spaëth D, Geoffrois L, Conroy T. Spaëth D, et al. Bull Cancer. 2000 Jan;87(1):93-6. Bull Cancer. 2000. PMID: 10673637 Review. French. No abstract available.
• Amelioration of chemotherapy-induced thrombocytopenia by GM-CSF: apparent dose and schedule dependency.

  Edmonson JH, Long HJ, Jeffries JA, Buckner JC, Colon-Otero G, Fitch TR. Edmonson JH, et al. J Natl Cancer Inst. 1989 Oct 4;81(19):1510-2. doi: 10.1093/jnci/81.19.1510-a. J Natl Cancer Inst. 1989. PMID: 2674462 No abstract available.